Compare StocksMDLZ vs PFE

Mondelez International, Inc. (MDLZ) vs Pfizer Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-06-19, MDLZ is overvalued at $60, with a DCF intrinsic value of $35 and a margin of safety of -71%. PFE is overvalued at $25, with an intrinsic value of $22 and a margin of safety of -12%. Of the two, PFE has the wider margin of safety.

MDLZ
Mondelez International, Inc.
$60.12
VS
PFE
Pfizer Inc.
$25.21

Rewards

MDLZ
    PFE
    • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
    • FCF yield of 8.6% is historically attractive — the business generates significant cash relative to its price.
    • Trailing P/E of 19.2x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.

    Risks

    MDLZ
      PFE
      • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
      • PEG ratio of 13.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
      • Free cash flow has declined at a 29.6% CAGR over the past 4 years — a concerning trend.

      Key Valuation Metrics

      Learn more →
      MDLZ
      PFE
      Valuation
      $2.85B
      Free Cash Flow
      $12.38B
      3.69%
      FCF Yield
      8.61%
      29.76
      Trailing P/E
      19.24
      17.75
      Forward P/E
      8.91
      Quality & Moat
      6.09%
      ROIC
      10.19%
      10.16%
      ROE
      8.31%
      28.77%
      Gross Margin
      74.80%
      1.02
      PEG Ratio
      13.77
      Balance Sheet Safety
      0.78
      Net Debt / Equity
      0.57
      N/A
      Interest Coverage
      N/A
      3.85
      Net Debt / EBITDA
      2.03
      3.22%
      Dividend Yield
      6.61%
      MDLZ: 2Ties: 1PFE: 9
      MDLZPFE

      Historical Fundamentals

      Learn more →
      MDLZ

      Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

      PFE

      Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

      Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

      $1 Retained Earnings Test

      Learn more →
      MDLZ
      $-4.39
      created per $1 retained over 3 years
      Market Cap Declined
      Σ Retained
      $5.03B
      Δ Market Cap
      $-22.05B
      Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
      > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
      PFE
      N/A
      Net losses over 3 years — test not applicable
      Company had negative cumulative retained earnings
      Σ Retained
      $-10.61B
      Δ Market Cap
      $-146.18B
      Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
      > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

      Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
      > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

      Discounted Cash Flow (DCF) Analysis

      Learn more →
      MDLZ
      71.1% Overvalued
      Price is 71.1% above estimated fair value
      Current Price: $60.12
      Fair Value: $35.15
      Strongly undervalued
      Undervalued
      Fairly valued
      Overvalued
      Strongly overvalued
      PFE
      12.3% Overvalued
      Price is 12.3% above estimated fair value
      Current Price: $25.21
      Fair Value: $22.46
      Strongly undervalued
      Undervalued
      Fairly valued
      Overvalued
      Strongly overvalued

      Reverse DCF — Market-Implied Growth

      Learn more →
      MDLZ

      What growth rate is the market pricing in at $60?

      +16.6%
      Market-Implied Owner Earnings Growth
      Standard FCF implies +15.0%

      The market implies +16.6% Owner Earnings growth, above historical trends.

      Standard FCF implies a demanding +15.0%, reflecting heavy growth investment.

      PFE

      What growth rate is the market pricing in at $25?

      +5.2%
      Market-Implied Owner Earnings Growth
      Standard FCF implies +4.5%

      The market implies +5.2% Owner Earnings growth, above historical trends.

      Standard FCF implies a demanding +4.5%, reflecting heavy growth investment.

      Economic Moat Score

      Learn more →
      MDLZ
      48/100
      Narrow Moat
      70+ Wide · 40-69 Narrow · <40 None

      Narrow moat with reinvestment efficiency as the key competitive advantage. Improving roic consistency would strengthen the moat.

      Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
      PFE
      35/100
      No Moat
      70+ Wide · 40-69 Narrow · <40 None

      No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

      Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

      Forensic Accounting

      Learn more →
      MDLZ
      -2.43
      Unlikely Manipulator
      Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

      M-Score Trend

      Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
      PFE
      -2.53
      Unlikely Manipulator
      Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

      M-Score Trend

      Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

      Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

      Ownership Breakdown

      Learn more →
      MDLZ
      Insiders 0.2%Institutions 90.1%Retail & Other 9.6%
      No. of Institutional Holders2,492
      High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
      PFE
      Insiders 0.1%Institutions 69.4%Retail & Other 30.5%
      No. of Institutional Holders3,744
      High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

      High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

      Insider Buying Activity

      Learn more →
      MDLZ
      0
      Buys (3M)
      0
      Buys (12M)
      No open market insider purchases found.
      Open market purchases · includes direct & indirect ownership · excludes option exercises
      PFE
      0
      Buys (3M)
      0
      Buys (12M)
      BLAYLOCK RONALD E
      Director
      $499,072
      @ $25.65 · 2025-02-13
      GOTTLIEB SCOTT
      Director
      $28,240
      @ $28.24 · 2024-10-30
      Open market purchases · includes direct & indirect ownership · excludes option exercises

      Open market purchases · includes direct & indirect ownership · excludes option exercises.

      Insider Selling Activity

      Learn more →
      MDLZ
      0
      Sells (3M)
      1
      Sells (12M)
      Total value (12M): $186,000
      VALLE GUSTAVO CARLOS
      Officer
      $186,000
      @ $62.00 · 2026-02-13
      Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
      PFE
      1
      Sells (3M)
      1
      Sells (12M)
      Total value (12M): $51,400
      DAMICO JENNIFER B.
      Officer
      $51,400
      @ $25.70 · 2026-06-09
      DAMICO JENNIFER B.
      Officer
      $64,825
      @ $25.93 · 2025-03-04
      DAMICO JENNIFER B.
      Officer
      $147,714
      @ $28.66 · 2024-08-13
      Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

      Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

      🎭 Mr. Market's Mood

      Learn more →
      MDLZ
      FearGreed
      😐Neutral(47/100)

      "Market is pricing this stock without strong emotion in either direction"

      Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
      PFE
      FearGreed
      😐Neutral(49/100)

      "Market is pricing this stock without strong emotion in either direction"

      Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

      Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

      ⚖️ Buffett Signal

      Learn more →
      MDLZ
      Awaiting DCF Data

      The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

      DCF Margin of Safety: N/AMr. Market's Mood: Neutral (47)
      PFE
      Awaiting DCF Data

      The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

      DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
      View MDLZ Full AnalysisView PFE Full Analysis

      Frequently Asked Questions: MDLZ vs PFE

      Is Mondelez International, Inc. or Pfizer Inc. more undervalued in 2026?

      Based on our discounted cash flow model, PFE trades at a -12.3% margin of safety (intrinsic value $22 vs. price $25), compared to MDLZ's -71.1% margin of safety (intrinsic $35 vs. $60).

      Which stock has a wider economic moat, Mondelez International, Inc. or Pfizer Inc.?

      MDLZ scores 48/100 (Narrow moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

      Is Pfizer Inc. in financial distress?

      PFE's Altman Z-Score of 2.1 places it in the Grey zone, signaling elevated bankruptcy risk. MDLZ scores 2.2 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

      Which company has better free cash flow, Mondelez International, Inc. or Pfizer Inc.?

      Pfizer Inc. (PFE) generates a 8.6% free cash flow yield, compared to Mondelez International, Inc.'s 3.7%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

      Which stock has higher return on invested capital, Mondelez International, Inc. or Pfizer Inc.?

      PFE earns 10.2% ROIC versus MDLZ's 6.1%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

      Which dividend is safer, Mondelez International, Inc.'s or Pfizer Inc.'s?

      MDLZ's dividend earns a safety score of 39/100 (Unsafe), compared to PFE's 24/100 (Unsafe). MDLZ has raised its dividend for 3 consecutive years.

      MDLZ vs PFE: Which Is the Better Buy in 2026? | SafetyMargin.io